Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2010-12-08 15:54:58 Beta-lactam antibiotics Microbiology Infectious diseases Beta-lactamase Klebsiella pneumoniae Proteus vulgaris Cephalosporin Ceftazidime Nosocomial infection Medicine Enterobacteria Health		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 244,44 KB Share Document on Facebook

	1035 CASE REPORT Extended Spectrum Beta Lactamase producing Cephalosporin resistant Salmonella Typhi, reported from Rawalpindi, Pakistan Tehmina Munir,1 Munir Lodhi,2 Jawad Khaliq Ansari,3 Saadia Andleeb,4 Mushtaq Ahmed DocID: 1qAvx - View Document
	emea_strap_url_cmyk_rev_en_std_cent.eps MASTER DocID: 1qpdm - View Document
	STATE OF CALIFORNIA STATEWIDE PHARMACEUTICAL PROGRAM COMMON DRUG FORMULARY DocID: 1q62Z - View Document
	I rarely recommend price of azithromycin fat burning supplement. To view content sources and attributions, refer to our editorial policy. Several high quality studies have never been done. Be sure to tell your doctor for DocID: 1pltJ - View Document
	Microsoft Word - Application Note 9 - Beta Lactam Decontamination - B DocID: 1nQjH - View Document